Literature DB >> 16200502

Identification of novel and conserved functional and structural elements of the G1 cyclin Cln3 important for interactions with the CDK Cdc28 in Saccharomyces cerevisiae.

Mary E Miller1, Frederick R Cross, Alison L Groeger, Katherine L Jameson.   

Abstract

Regions of the budding yeast G1 cyclin Cln3 were characterized using mutational analysis and viability assays to identify functionally relevant and novel mutant alleles of CLN3. Cyclin proteins are conserved, and Cln3 contains a region with homology to the cyclin box, which is thought to mediate physical interactions with the cyclin-dependent kinase. CLN3 was found to have characteristics similar to the conserved cyclin fold found in higher eukaryotic cyclin boxes, which consist of five alpha-helices. Peptide linker sequences inserted within helices 1, 2, 3 and 5 resulted in a loss of Cln3 function, showing cyclin fold structure similar to that previously observed for the G1 cyclin Cln2. A clustered-charge-to-alanine scan mutagenesis revealed two regions of Cln3 important for Cln3-dependent viability. The first region encompasses the conserved cyclin box. The second region is identified with alanine substitutions located well past the cyclin box, just prior to the C-terminal region of Cln3 important for protein stability. Cln3 with mutational changes in each of these regions are expressed at steady-state levels higher than wild-type Cln3, and show some defect in binding to Cdc28. The conserved hydrophobic patch domain (HPD) of cyclins is present within the first helix of the cyclin box. Alanine substitutions introduced into the HPD of Cln3 and Cln2 show functional defects while maintaining physical interaction with Cdc28 as measured by co-immunoprecipitation assay. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200502     DOI: 10.1002/yea.1292

Source DB:  PubMed          Journal:  Yeast        ISSN: 0749-503X            Impact factor:   3.239


  8 in total

1.  Ribosome biogenesis is sensed at the Start cell cycle checkpoint.

Authors:  Kara A Bernstein; Franziska Bleichert; James M Bean; Frederick R Cross; Susan J Baserga
Journal:  Mol Biol Cell       Date:  2006-12-27       Impact factor: 4.138

2.  G1 cyclin-Cdk promotes cell cycle entry through localized phosphorylation of RNA polymerase II.

Authors:  Mardo Kõivomägi; Matthew P Swaffer; Jonathan J Turner; Georgi Marinov; Jan M Skotheim
Journal:  Science       Date:  2021-10-14       Impact factor: 47.728

3.  Expression of genomic AtCYCD2;1 in Arabidopsis induces cell division at smaller cell sizes: implications for the control of plant growth.

Authors:  Ruhu Qi; Peter Crook Lloyd John
Journal:  Plant Physiol       Date:  2007-05-18       Impact factor: 8.340

4.  Drug targets for cell cycle dysregulators in leukemogenesis: in silico docking studies.

Authors:  Archana Jayaraman; Kaiser Jamil
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

5.  Reliable cell cycle commitment in budding yeast is ensured by signal integration.

Authors:  Xili Liu; Xin Wang; Xiaojing Yang; Sen Liu; Lingli Jiang; Yimiao Qu; Lufeng Hu; Qi Ouyang; Chao Tang
Journal:  Elife       Date:  2015-01-14       Impact factor: 8.140

6.  Dilution of the cell cycle inhibitor Whi5 controls budding-yeast cell size.

Authors:  Kurt M Schmoller; J J Turner; M Kõivomägi; Jan M Skotheim
Journal:  Nature       Date:  2015-09-21       Impact factor: 49.962

7.  Bayesian Orthogonal Least Squares (BOLS) algorithm for reverse engineering of gene regulatory networks.

Authors:  Chang Sik Kim
Journal:  BMC Bioinformatics       Date:  2007-07-13       Impact factor: 3.169

8.  Yeast Cip1 is activated by environmental stress to inhibit Cdk1-G1 cyclins via Mcm1 and Msn2/4.

Authors:  Ya-Lan Chang; Shun-Fu Tseng; Yu-Ching Huang; Zih-Jie Shen; Pang-Hung Hsu; Meng-Hsun Hsieh; Chia-Wei Yang; Silvia Tognetti; Berta Canal; Laia Subirana; Chien-Wei Wang; Hsiao-Tan Chen; Chi-Ying Lin; Francesc Posas; Shu-Chun Teng
Journal:  Nat Commun       Date:  2017-07-04       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.